Home › Idiopathic Pulmonary Fibrosis › Virginia › Richmond
Idiopathic Pulmonary Fibrosis clinical trials in Richmond, VA
3 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
RecruitingPhase 2
- Research Site, Richmond
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
RecruitingPhase 3
- Pulmonary Associates of Richmond Inc (Par) - West Broad Location, Richmond
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Virginia Commonwealth University Medical Center /ID# 277992, Richmond
Idiopathic Pulmonary Fibrosis trials in other cities
- Birmingham, AL9 studies
- New York City, NY8 studies
- Kansas City, KS7 studies
- Philadelphia, PA7 studies
- Los Angeles, CA7 studies
- Chicago, IL6 studies
- Aurora, CO6 studies
- Durham, NC6 studies
- Nashville, TN5 studies
- Dallas, TX5 studies
- Houston, TX5 studies
- Charleston, SC5 studies
Other studies in Richmond
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer19 studies
- Heart Failure16 studies
- Lung Cancer14 studies
- Cardiovascular Disease13 studies
- Colorectal Cancer13 studies
- Steatotic Liver Disease12 studies
- Acute Myeloid Leukemia12 studies
- Metastatic Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Melanoma11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.